Literature DB >> 12112793

Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland.

R Dinwiddie1, N Sharief, O Crawford.   

Abstract

Interstitial lung disease (ILD) of unknown etiology in immunocompetent patients is rare in children. A national survey was carried out in the United Kingdom and Ireland over a 3-year period in order to identify prevalence, age distribution, histopathology, natural history of the illness, and response to current treatment.Forty-six cases were identified, including 29 males and 17 females. Seventy-six percent presented in the first year of life. Nine (16%) occurred within four families. Conventional treatment with pulsed methylprednisolone, prednisolone, or hydroxychloroquine, singly or in combination, resulted in an excellent response in 65% of cases. Seven children died (15%). The recurrence risk for further children within the same family to develop ILD is estimated to be approximately 10%. The prevalence rate of this condition in the United Kingdom and Ireland during the period of study for children aged 0-16 years is estimated to be 3.6 cases/million. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12112793     DOI: 10.1002/ppul.10125

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  30 in total

Review 1.  Childhood interstitial lung diseases: an 18-year retrospective analysis.

Authors:  Jennifer J Soares; Gail H Deutsch; Paul E Moore; Mohammad F Fazili; Eric D Austin; Rebekah F Brown; Andrew G Sokolow; Melissa A Hilmes; Lisa R Young
Journal:  Pediatrics       Date:  2013-09-30       Impact factor: 7.124

2.  Autoimmune pulmonary proteinosis in a Chilean teenager, a rare aetiology of interstitial lung disease.

Authors:  Alexis Strickler; Maria Lina Boza; Andres Koppmann; Sergio Gonzalez
Journal:  BMJ Case Rep       Date:  2014-05-23

Review 3.  Interstitial lung disease in children.

Authors:  Christin S Kuo; Lisa R Young
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

4.  New Applications of Old Drugs as Novel Therapies in Idiopathic Pulmonary Fibrosis. Metformin, Hydroxychloroquine, and Thyroid Hormone.

Authors:  Edward P Manning; Ashley Losier; Nkiruka Emeagwali; Changwan Ryu; Shyoko Honiden
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

5.  Pulmonary involvement in Niemann-Pick C type 1.

Authors:  Orna Staretz-Chacham; M Aviram; I Morag; A Goldbart; E Hershkovitz
Journal:  Eur J Pediatr       Date:  2018-07-31       Impact factor: 3.183

6.  Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany.

Authors:  Matthias Griese; Melanie Haug; Frank Brasch; Achim Freihorst; Peter Lohse; Rüdiger von Kries; Theodor Zimmermann; Dominik Hartl
Journal:  Orphanet J Rare Dis       Date:  2009-12-12       Impact factor: 4.123

7.  Pulmonary interstitial glycogenosis.

Authors:  Michael Lanfranchi; Sandra M Allbery; Lisa Wheelock; Deborah Perry
Journal:  Pediatr Radiol       Date:  2009-11-10

Review 8.  Rare Lung Diseases: Interstitial Lung Diseases and Lung Manifestations of Rheumatological Diseases.

Authors:  Mahesh Babu Ramamurthy; Daniel Y T Goh; Michael Teik Chung Lim
Journal:  Indian J Pediatr       Date:  2015-08-20       Impact factor: 1.967

Review 9.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

10.  Chronic pneumonitis of infancy: high-resolution CT findings.

Authors:  Øystein E Olsen E; Neil J Sebire; Adam Jaffe; Catherine M Owens
Journal:  Pediatr Radiol       Date:  2003-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.